Global Neurostimulation Devices Market 2018 | Major Key Players – Medtronic, Boston Scientific, St. Jude Medical (Abbott), LivaNova, Nevro Analysis And Forecast : MI Reports

Description :

Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.

Scope of the Report:
This report focuses on the Neurostimulation Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The global average price of implantable neurostimulation devices is in the fluctuating trend, 22.10 K USD/Unit in 2012 to 21.24 K USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.

The classification of implantable neurostimulation devices includes spinal cord stimulation (SCS), gastric electric stimulation (GES), deep brain stimulation (DBS), sacral nerve stimulation (SNS), vagus nerve stimulation (VNS) and other type, and the proportion of spinal cord stimulation (SCS) in 2016 is about 57%, and the proportion is in increasing trend from 2012 to 2016.

Implantable neurostimulation devices are widely used to treat pain management, parkinson’s disease, urinary and fecal incontinence, epilepsy, gastroparesis and other field. The most proportion of implantable neurostimulation devices is used for pain management, and the consumption proportion in 2016 is about 55%.

North America region is the largest supplier of implantable neurostimulation devices, with a production market share nearly 82% in 2016. Europe is the second largest supplier of implantable neurostimulation devices, enjoying production market share nearly 12% in 2016.

North America is the largest consumption place, with a consumption market share nearly 42% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 31%.

Market competition is intense. Medtronic, Boston Scientific, St. Jude Medical (Abbott), etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The worldwide market for Neurostimulation Devices is expected to grow at a CAGR of roughly 11.2% over the next five years, will reach 8120 million US$ in 2023, from 4290 million US$ in 2017, according to a new GIR (Global Info Research) study.

Request For sample Report @ http://www.wiseguyreports.com/sample-request/3257895-global-north-america-europe-asia-pacific-south-america

Market Segment by Manufacturers, this report covers
Medtronic
Boston Scientific
St. Jude Medical (Abbott)
LivaNova
Nevro
NeuroPace
Beijing Pins
Synapse Biomedical

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Spinal Cord Stimulation (SCS)
Gastric Electric Stimulation (GES)
Deep Brain Stimulation (DBS)
Sacral Nerve Stimulation (SNS)
Vagus Nerve Stimulation (VNS)
Other

Market Segment by Applications, can be divided into
Pain Management
Parkinson’s Disease
Urinary and Fecal Incontinence
Epilepsy
Gastroparesis
Other

Complete Report Details https://www.wiseguyreports.com/reports/3257895-global-north-america-europe-asia-pacific-south-america

Table Of Content

1 Market Overview
1.1 Neurostimulation Devices Introduction
1.2 Market Analysis by Type
1.2.1 Spinal Cord Stimulation (SCS)
1.2.2 Gastric Electric Stimulation (GES)
1.2.3 Deep Brain Stimulation (DBS)
1.2.4 Sacral Nerve Stimulation (SNS)
1.2.5 Vagus Nerve Stimulation (VNS)
1.2.6 Other
1.3 Market Analysis by Applications
1.3.1 Pain Management
1.3.2 Parkinson’s Disease
1.3.3 Urinary and Fecal Incontinence
1.3.4 Epilepsy
1.3.5 Gastroparesis
1.3.6 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force

2 Manufacturers Profiles
2.1 Medtronic
2.1.1 Business Overview
2.1.1.1 Medtronic Description
2.1.1.2 Medtronic Headquarter, Main Business and Finance Overview
2.1.2 Medtronic Neurostimulation Devices Product Introduction
2.1.2.1 Neurostimulation Devices Production Bases, Sales Regions and Major Competitors
2.1.2.2 Neurostimulation Devices Product Information
2.1.3 Medtronic Neurostimulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Medtronic Neurostimulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Medtronic Neurostimulation Devices Market Share in 2017
2.2 Boston Scientific
2.2.1 Business Overview
2.2.1.1 Boston Scientific Description
2.2.1.2 Boston Scientific Headquarter, Main Business and Finance Overview
2.2.2 Boston Scientific Neurostimulation Devices Product Introduction
2.2.2.1 Neurostimulation Devices Production Bases, Sales Regions and Major Competitors
2.2.2.2 Neurostimulation Devices Product Information
2.2.3 Boston Scientific Neurostimulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Boston Scientific Neurostimulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Boston Scientific Neurostimulation Devices Market Share in 2017
2.3 St. Jude Medical (Abbott)
2.3.1 Business Overview
2.3.1.1 St. Jude Medical (Abbott) Description
2.3.1.2 St. Jude Medical (Abbott) Headquarter, Main Business and Finance Overview
2.3.2 St. Jude Medical (Abbott) Neurostimulation Devices Product Introduction
2.3.2.1 Neurostimulation Devices Production Bases, Sales Regions and Major Competitors
2.3.2.2 Neurostimulation Devices Product Information
2.3.3 St. Jude Medical (Abbott) Neurostimulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 St. Jude Medical (Abbott) Neurostimulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global St. Jude Medical (Abbott) Neurostimulation Devices Market Share in 2017
2.4 LivaNova
2.4.1 Business Overview
2.4.1.1 LivaNova Description
2.4.1.2 LivaNova Headquarter, Main Business and Finance Overview
2.4.2 LivaNova Neurostimulation Devices Product Introduction
2.4.2.1 Neurostimulation Devices Production Bases, Sales Regions and Major Competitors
2.4.2.2 Neurostimulation Devices Product Information
2.4.3 LivaNova Neurostimulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 LivaNova Neurostimulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global LivaNova Neurostimulation Devices Market Share in 2017
2.5 Nevro
2.5.1 Business Overview
2.5.1.1 Nevro Description
2.5.1.2 Nevro Headquarter, Main Business and Finance Overview
2.5.2 Nevro Neurostimulation Devices Product Introduction
2.5.2.1 Neurostimulation Devices Production Bases, Sales Regions and Major Competitors
2.5.2.2 Neurostimulation Devices Product Information
2.5.3 Nevro Neurostimulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Nevro Neurostimulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Nevro Neurostimulation Devices Market Share in 2017
2.6 NeuroPace
2.6.1 Business Overview
2.6.1.1 NeuroPace Description
2.6.1.2 NeuroPace Headquarter, Main Business and Finance Overview
2.6.2 NeuroPace Neurostimulation Devices Product Introduction
2.6.2.1 Neurostimulation Devices Production Bases, Sales Regions and Major Competitors
2.6.2.2 Neurostimulation Devices Product Information
2.6.3 NeuroPace Neurostimulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 NeuroPace Neurostimulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global NeuroPace Neurostimulation Devices Market Share in 2017
2.7 Beijing Pins
2.7.1 Business Overview
2.7.1.1 Beijing Pins Description
2.7.1.2 Beijing Pins Headquarter, Main Business and Finance Overview
2.7.2 Beijing Pins Neurostimulation Devices Product Introduction
2.7.2.1 Neurostimulation Devices Production Bases, Sales Regions and Major Competitors
2.7.2.2 Neurostimulation Devices Product Information
2.7.3 Beijing Pins Neurostimulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Beijing Pins Neurostimulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Beijing Pins Neurostimulation Devices Market Share in 2017
2.8 Synapse Biomedical
2.8.1 Business Overview
2.8.1.1 Synapse Biomedical Description
2.8.1.2 Synapse Biomedical Headquarter, Main Business and Finance Overview
2.8.2 Synapse Biomedical Neurostimulation Devices Product Introduction
2.8.2.1 Neurostimulation Devices Production Bases, Sales Regions and Major Competitors
2.8.2.2 Neurostimulation Devices Product Information
2.8.3 Synapse Biomedical Neurostimulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Synapse Biomedical Neurostimulation Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Synapse Biomedical Neurostimulation Devices Market Share in 2017

3 Global Neurostimulation Devices Market Competition, by Manufacturer
3.1 Global Neurostimulation Devices Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Neurostimulation Devices Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Neurostimulation Devices Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Neurostimulation Devices Manufacturer Market Share in 2017
3.4.2 Top 5 Neurostimulation Devices Manufacturer Market Share in 2017
3.5 Market Competition Trend

4 Global Neurostimulation Devices Market Analysis by Regions
4.1 Global Neurostimulation Devices Sales, Revenue and Market Share by Regions
4.1.1 Global Neurostimulation Devices Sales by Regions (2013-2018)
4.1.2 Global Neurostimulation Devices Revenue by Regions (2013-2018)
4.2 North America Neurostimulation Devices Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Neurostimulation Devices Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Neurostimulation Devices Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Neurostimulation Devices Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Neurostimulation Devices Sales, Revenue and Growth Rate (2013-2018)

5 North America Neurostimulation Devices by Countries, Type, Application and Manufacturers
5.1 North America Neurostimulation Devices Sales, Revenue and Market Share by Countries
5.1.1 North America Neurostimulation Devices Sales by Countries (2013-2018)
5.1.2 North America Neurostimulation Devices Revenue by Countries (2013-2018)
5.1.3 United States Neurostimulation Devices Sales and Growth Rate (2013-2018)
5.1.4 Canada Neurostimulation Devices Sales and Growth Rate (2013-2018)
5.1.5 Mexico Neurostimulation Devices Sales and Growth Rate (2013-2018)
5.2 North America Neurostimulation Devices Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Neurostimulation Devices Sales by Manufacturers (2016-2017)
5.2.2 North America Neurostimulation Devices Revenue by Manufacturers (2016-2017)
5.3 North America Neurostimulation Devices Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Neurostimulation Devices Sales and Sales Share by Type (2013-2018)
5.3.2 North America Neurostimulation Devices Revenue and Revenue Share by Type (2013-2018)
5.4 North America Neurostimulation Devices Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Neurostimulation Devices Sales and Sales Share by Application (2013-2018)
5.4.2 North America Neurostimulation Devices Revenue and Revenue Share by Application (2013-2018)

6 Europe Neurostimulation Devices by Countries, Type, Application and Manufacturers
6.1 Europe Neurostimulation Devices Sales, Revenue and Market Share by Countries
6.1.1 Europe Neurostimulation Devices Sales by Countries (2013-2018)
6.1.2 Europe Neurostimulation Devices Revenue by Countries (2013-2018)
6.1.3 Germany Neurostimulation Devices Sales and Growth Rate (2013-2018)
6.1.4 UK Neurostimulation Devices Sales and Growth Rate (2013-2018)
6.1.5 France Neurostimulation Devices Sales and Growth Rate (2013-2018)
6.1.6 Russia Neurostimulation Devices Sales and Growth Rate (2013-2018)
6.1.7 Italy Neurostimulation Devices Sales and Growth Rate (2013-2018)
6.2 Europe Neurostimulation Devices Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Neurostimulation Devices Sales by Manufacturers (2016-2017)
6.2.2 Europe Neurostimulation Devices Revenue by Manufacturers (2016-2017)
6.3 Europe Neurostimulation Devices Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Neurostimulation Devices Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Neurostimulation Devices Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Neurostimulation Devices Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Neurostimulation Devices Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Neurostimulation Devices Revenue and Revenue Share by Application (2013-2018)

7 Asia-Pacific Neurostimulation Devices by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Neurostimulation Devices Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Neurostimulation Devices Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Neurostimulation Devices Revenue by Countries (2013-2018)
7.1.3 China Neurostimulation Devices Sales and Growth Rate (2013-2018)
7.1.4 Japan Neurostimulation Devices Sales and Growth Rate (2013-2018)
7.1.5 Korea Neurostimulation Devices Sales and Growth Rate (2013-2018)
7.1.6 India Neurostimulation Devices Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Neurostimulation Devices Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Neurostimulation Devices Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Neurostimulation Devices Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Neurostimulation Devices Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Neurostimulation Devices Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Neurostimulation Devices Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Neurostimulation Devices Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Neurostimulation Devices Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Neurostimulation Devices Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Neurostimulation Devices Revenue and Revenue Share by Application (2013-2018)

Continued …

CONTACT US:

NORAH TRENT

Partner Relations & MarkeNeurostimulation Devicesg Manager

sales@wiseguyreports.com

http://www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Office No.528,Amanora Chambers,Magarpatta Road,Hadapsar,Pune-411028.

This release was published on openPR.